170 related articles for article (PubMed ID: 38002585)
1. BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review.
Matrone A; Citro F; Gambale C; Prete A; Minaldi E; Ciampi R; Ramone T; Materazzi G; Torregrossa L; Elisei R
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002585
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
Afkhami M; Karunamurthy A; Chiosea S; Nikiforova MN; Seethala R; Nikiforov YE; Coyne C
Thyroid; 2016 Feb; 26(2):242-7. PubMed ID: 26422023
[TBL] [Abstract][Full Text] [Related]
3. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
4. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
Trovisco V; Soares P; Preto A; de Castro IV; Lima J; Castro P; Máximo V; Botelho T; Moreira S; Meireles AM; Magalhães J; Abrosimov A; Cameselle-Teijeiro J; Sobrinho-Simões M
Virchows Arch; 2005 Jun; 446(6):589-95. PubMed ID: 15902486
[TBL] [Abstract][Full Text] [Related]
5. BRAF
Macerola E; Torregrossa L; Ugolini C; Bakkar S; Vitti P; Fadda G; Basolo F
Int J Surg Pathol; 2017 Jun; 25(4):348-351. PubMed ID: 28112041
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Spectrum of
De Leo A; Serban D; Maloberti T; Sanza V; Coluccelli S; Altimari A; Gruppioni E; Chiarucci F; Corradini AG; Repaci A; Colapinto A; Nannini M; Pantaleo MA; de Biase D; Tallini G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835466
[TBL] [Abstract][Full Text] [Related]
7. BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma.
Pennelli G; Vianello F; Barollo S; Pezzani R; Merante Boschin I; Pelizzo MR; Mantero F; Rugge M; Mian C
Thyroid; 2011 Dec; 21(12):1393-6. PubMed ID: 22136270
[TBL] [Abstract][Full Text] [Related]
8. BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.
Monti E; Bovero M; Mortara L; Pera G; Zupo S; Gugiatti E; Dono M; Massa B; Ansaldo GL; Massimo G
Int J Endocrinol; 2015; 2015():138734. PubMed ID: 26693224
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib in Metastatic Papillary Thyroid Carcinoma with
Caterino M; Pirozzi M; Facchini S; Zotta A; Sica A; Lo Giudice G; Rauso R; Varriale E; Ciardiello F; Fasano M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630083
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Lee SE; Hwang TS; Choi YL; Han HS; Kim WS; Jang MH; Kim SK; Yang JH
Thyroid; 2016 Jul; 26(7):901-10. PubMed ID: 27184112
[TBL] [Abstract][Full Text] [Related]
12. A Case of Multifocal Papillary Thyroid Carcinoma Consisting of One Encapsulated Follicular Variant with BRAF K601E Mutation and Three Conventional Types with BRAF V600E Mutation.
Kim WY; Ko YS; Hwang TS; Han HS; Lim SD; Kim WS; Oh SY
Korean J Pathol; 2013 Jun; 47(3):293-8. PubMed ID: 23837025
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutations in thyroid tumors from an ethnically diverse group.
Schulten HJ; Salama S; Al-Mansouri Z; Alotibi R; Al-Ghamdi K; Al-Hamour OA; Sayadi H; Al-Aradati H; Al-Johari A; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Hered Cancer Clin Pract; 2012 Aug; 10(1):10. PubMed ID: 22925390
[TBL] [Abstract][Full Text] [Related]
14. Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer.
Murugan AK; Qasem E; Al-Hindi H; Shi Y; Alzahrani AS
J Transl Med; 2016 Jul; 14(1):204. PubMed ID: 27387551
[TBL] [Abstract][Full Text] [Related]
15. Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations.
Attia D; Lurie A; Zhai Q; Mesko T; Smallridge R
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606114
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
Newfield RS; Jiang W; Sugganth DX; Hantash FM; Lee E; Newbury RO
Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
[TBL] [Abstract][Full Text] [Related]
17. BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma.
Givens DJ; Buchmann LO; Agarwal AM; Grimmer JF; Hunt JP
Laryngoscope; 2014 Sep; 124(9):E389-93. PubMed ID: 24604709
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.
Tang KT; Lee CH
J Chin Med Assoc; 2010 Mar; 73(3):113-28. PubMed ID: 20230995
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.
Barollo S; Pezzani R; Cristiani A; Redaelli M; Zambonin L; Rubin B; Bertazza L; Zane M; Mucignat-Caretta C; Bulfone A; Pennelli G; Casal Ide E; Pelizzo MR; Mantero F; Moro S; Mian C
Thyroid; 2014 May; 24(5):809-19. PubMed ID: 24295088
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]